Christopher Johnson

Shares in the owner of the UK’s stock exchange have barely moved in five years, despite a strong run for global markets.

Fernando Fernandez is betting on emerging markets and premium brands to reignite growth—will shareholders benefit?

Fund managers who hold the FTSE 100 luxury stock explain the factors behind the revival.

AstraZeneca stock is trading in three-star territory.

Norway’s ODIN Bærekraft fund and the UK’s Fundsmith Equity are funds with overweight positions in Novo stock.

The Danish drugmaker behind weight-loss drugs Ozempic and Wegovy lost a quarter of its value after a profit warning.

Volkswagen stock is undervalued, despite a potential hit to its US and China strategies.

Rolls-Royce and Centrica are two stocks to watch.

Morningstar’s Michael Field believes that the rotation out of US stocks into European assets will persist.

While the UK has agreed a trade deal with the US, negotiations with the EU continue ahead of the July 9 deadline.

The ECB, defense stocks, Bunds and the euro.

Guinness Global Equity Income Fund manager highlights two French and one German dividend stocks.

Luxury, tech, and energy sectors have been leading the recovery.

Tech and consumer cyclical stocks have been the best performers over a week, but they are still in negative territory for the year.

European renewable energy stocks are trading at very cheap valuations.

Fund managers explain the drivers of this latest rally and whether it’s sustainable.

Jose Garcia Zarate explains to Christopher Johnson why 2024 was another record year, why iShares is so dominant and the rise of active ETFs.

Thomas Becket discusses the implications of Trump 2.0 on the US and the world